Cargando…
Analytical validation of the CellMax platform for early detection of cancer by enumeration of rare circulating tumor cells
The CellMax (CMx®) platform was developed to enrich for epithelial circulating tumor cells (CTCs) in the whole blood. This report provides assay performance data, including accuracy, linearity, limit of blank, limit of detection (LOD), specificity, and precision of enumeration of cancer cell line ce...
Autores principales: | Gupta, Pratyush, Gulzar, Zulfiqar, Hsieh, Ben, Lim, Austin, Watson, Drew, Mei, Rui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6939390/ https://www.ncbi.nlm.nih.gov/pubmed/31921364 http://dx.doi.org/10.1177/1849454419899214 |
Ejemplares similares
-
Circulating Tumor Cells, Enumeration and Beyond
por: Hou, Jian-Mei, et al.
Publicado: (2010) -
Detection and enumeration of circulating tumor cells based on their invasive property
por: Wang, Haizhen, et al.
Publicado: (2015) -
Beyond Circulating Tumor Cell Enumeration: Cell-Based Liquid Biopsy to Assess Protein Biomarkers and Cancer Genomics Using the RareCyte(®) Platform
por: Kaldjian, Eric P., et al.
Publicado: (2022) -
Method validation of circulating tumour cell enumeration at low cell counts
por: Cummings, Jeffrey, et al.
Publicado: (2013) -
Retracing Circulating Tumour Cells for Biomarker Characterization after Enumeration
por: Frandsen, Anders S., et al.
Publicado: (2015)